Brendon Neuen

77PUBLICATIONS
197CO-AUTHORS
Cardiology (incl. cardiovascular diseases)PharmacogenomicsMajor global burdens of diseasePharmaceutical delivery technologiesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Sep 05, 2026
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes.

|Sep 04, 2026
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

|Sep 02, 2026
ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.

|Aug 17, 2026
Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes.

|Aug 13, 2026
Cardiovascular Risk Prediction with the Kidney Failure Risk Equation in the Chronic Renal Insufficiency Study.

|Jul 28, 2026
Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025.

Pageof 13

Frequent Collaborators

33 joint publications

Hiddo Jl Heerspink

30 joint publications

Clare Arnott

18 joint publications

Bruce Neal

17 joint publications

Muthiah Vaduganathan